85.14 
0.83(0.98%) May 21
| Prev Close: | 85.14 |
|---|
| Open: | 83.47 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 83.17 - 85.14 |
|---|
| 52wk Range: | 18.50 - 85.14 |
|---|
| Volume: | 2,296,778 |
|---|
| Avg Vol (3m): | 11,750 |
|---|
| Market Cap: | 112.67B |
|---|
| P/E (ttm): | 27.17 |
|---|
| EPS (ttm): | 3.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- French and Benelux stocks-Factors to watch on May 22at Reuters(Wed 12:38AM EDT)
- Novartis Ramping Up Alzheimer’s Pursuit as Rivals’ Drugs Failat Bloomberg(Tue, May 21)
- Regeneron, Sanofi asthma drug seen as potential game changerat Reuters(Tue, May 21)
- Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global ConsolidationBusiness Wire(Tue, May 21)
- Sanofi, Roll Global, Heineken, WWE: Intellectual Propertyat Bloomberg(Tue, May 21)
- Regeneron settles all pending litigation with Roche's Genentechat Reuters(Mon, May 20)
- Merck Insomnia Drug Safer at Lower Dose, FDA Staff Saysat Bloomberg(Mon, May 20)
- FDA staff says Merck's sleep drug effective, questions dosageat Reuters(Mon, May 20)
- FDA staff say Merck's sleep drug effective, question dose levelsat Reuters(Mon, May 20)
- Sanofi, French Government at Odds Over Fate of Research Siteat Bloomberg(Fri, May 17)
- Sanofi says will keep Toulouse research siteat Reuters(Fri, May 17)
- Sanofi says myelofibrosis treatment study positiveat Reuters(Fri, May 17)
- Lack of milestone payments pushes Zealand Pharma to lossat Reuters(Wed, May 15)
- Sanofi recruits patients for arthritis trialsat Reuters(Wed, May 15)
- French and Benelux stocks-Factors to watch on May 15at Reuters(Wed, May 15)
Reports
- No Reports available for SAN.PA at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments.
View More